Dr. Mark Barry Abelson, MD

  • MA
  • Ophthalmologist
NPI1811990682
Publications
27
Industry payments
$48
State license
1
Year NPI issued
2005
Practice address
MA
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Find Dr. Abelson's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mark Barry Abelson is an ophthalmologist in Massachusetts

Dr. Abelson practices in Massachusetts.

Dr. Abelson's NPI, 1811990682, was assigned on May 24, 2005. Dr. Abelson holds Massachusetts license 37429.

NPI and contact details
NPI enumeration date
May 24, 2005
NPI status
Active
Professional email
Get email
Personal email
Get email
Mobile number
Get number

Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data

Dmand AI tracks the EHR system at Dr. Mark Barry Abelson's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abelson practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dr. Abelson's practiceAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Abelson practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mark Barry Abelson is one of 617 ophthalmologists in Massachusetts

Ophthalmology is Dr. Abelson's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Abelson is licensed in Massachusetts.

Specialties and state licenses

  • Ophthalmology, MassachusettsPrimaryLicense 37429 · taxonomy 207W00000X

Ophthalmologists near Dr. Abelson

Counts of ophthalmologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mark Barry Abelson has 27 publications on record

Dmand AI links 27 papers to Dr. Abelson, published from 2011 to 2025. 2013 was the busiest year, with 4. The most frequent topics are Dry Eye Syndromes, Conjunctivitis, Allergic and Anti-Allergic Agents. Dr. Abelson has published most often in Clin Ophthalmol. Dr. Abelson's most frequent co-authors are Keith J. Lane, MD, Paul G. Arrigg, MD and Gail L. Torkildsen, MD.

Papers27
Years published2011 to 2025

Dr. Abelson's papers by year, 2013 to 2025

Topics Dr. Abelson writes about most

  • Dry Eye Syndromes
  • Conjunctivitis, Allergic
  • Anti-Allergic Agents
  • Double-Blind Method
  • Blinking
  • Cornea
  • Ophthalmic Solutions
  • Administration, Ophthalmic

Dr. Abelson's most frequent co-authors

Recent publications by Dr. Abelson

See all 27 publications and co-authors

See who Dr. Abelson researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Abelson works with, so you can find a warm path to the right ophthalmologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mark Barry Abelson received $48 in industry payments in 2019

CMS Open Payments shows 1 general payment to Dr. Abelson from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $48.

Companies that paid Dr. Abelson the most, 2019 to 2019

Share is of all general payments to this clinician.

See all payments to Dr. Abelson

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Mark Barry Abelson's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mark Barry Abelson

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mark Barry Abelson's NPI number?

Dr. Mark Barry Abelson's NPI number is 1811990682. It was assigned on May 24, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Mark Barry Abelson?

Dr. Mark Barry Abelson is an ophthalmologist in Massachusetts. The primary specialty in the NPI Registry is Ophthalmology Physician (taxonomy code 207W00000X).

What is Dr. Mark Barry Abelson's medical license number?

Dr. Abelson holds Massachusetts license 37429.

Has Dr. Mark Barry Abelson received payments from drug or device companies?

CMS Open Payments shows $48 in general payments to Dr. Abelson from 1 company from 2019 to 2019. The largest total came from Alcon Laboratories Inc.

How long has Dr. Mark Barry Abelson been practicing?

Dr. Abelson's NPI was assigned in 2005.

Does Dr. Mark Barry Abelson do research?

Dmand AI links 27 publications to Dr. Abelson, published from 2011 to 2025.

Who does Dr. Mark Barry Abelson publish with?

Dr. Abelson's most frequent co-authors are Keith J. Lane, MD (11 shared papers), Paul G. Arrigg, MD (2 shared papers) and Gail L. Torkildsen, MD (2 shared papers).

Selling to ophthalmology practices?

See ophthalmologists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)